Material Event - Form 8-K

Item 3.01 Notice of Delisting or Failure To Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On May 1, 2024, Biotricity Inc. (the "Company") received a letter from The Nasdaq Stock Market ("Nasdaq") stating that it is not in compliance with the Nasdaq Listing Rule 5620(a) (the "Rule") requiring that the Company hold an annual meeting of stockholders within 12 months of the end of its fiscal year. The notification received has no immediate effect on the Company's continued listing on the Nasdaq Capital Market, subject to its compliance with the other continued listing requirements.

In the letter dated May 1, 2024, Nasdaq notified the Company that this serves as an additional basis for delisting of the Company's securities from Nasdaq and that the letter was formal notification that Nasdaq's Hearings Panel (the "Panel") will consider the matter in their decision regarding the Company's continued listing on Nasdaq following the Company's recent hearing before the Panel on April 9, 2024. The Company was instructed to present its views with respect to this additional deficiency to the Panel in writing no later than May 8, 2024.

The Company intends to hold a stockholder meeting as soon as practicable and will provide public notice of such meeting.